These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11568949)

  • 1. Correlation coefficient estimation involving a left censored laboratory assay variable.
    Lyles RH; Fan D; Chuachoowong R
    Stat Med; 2001 Oct; 20(19):2921-33. PubMed ID: 11568949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy.
    Debiaggi M; Zara F; Spinillo A; De Santolo A; Maserati R; Bruno R; Sacchi P; Achilli G; Pistorio A; Romero E; Filice G
    Eur J Clin Microbiol Infect Dis; 2001 Feb; 20(2):91-6. PubMed ID: 11305478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.
    Mofenson LM; Lambert JS; Stiehm ER; Bethel J; Meyer WA; Whitehouse J; Moye J; Reichelderfer P; Harris DR; Fowler MG; Mathieson BJ; Nemo GJ
    N Engl J Med; 1999 Aug; 341(6):385-93. PubMed ID: 10432323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlating two viral load assays with known detection limits.
    Lyles RH; Williams JK; Chuachoowong R
    Biometrics; 2001 Dec; 57(4):1238-44. PubMed ID: 11764265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
    Sperling RS; Shapiro DE; Coombs RW; Todd JA; Herman SA; McSherry GD; O'Sullivan MJ; Van Dyke RB; Jimenez E; Rouzioux C; Flynn PM; Sullivan JL
    N Engl J Med; 1996 Nov; 335(22):1621-9. PubMed ID: 8965861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of two dosing regimens of zidovudine in Thai adults with early symptomatic HIV infection. Conducting clinical HIV trials in South-East Asia.
    Phanuphak P; Grayson ML; Sirivichayakul S; Suwanagool S; Ruxrungtham K; Hanvanich M; Ratanasuwan W; Ubolyam S; Hughes MD; Wanke CA; Hammer SM
    Aust N Z J Med; 2000 Feb; 30(1):11-20. PubMed ID: 10800872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervicovaginal human immunodeficiency virus secretion and plasma viral load in human immunodeficiency virus-seropositive women.
    Uvin SC; Caliendo AM
    Obstet Gynecol; 1997 Nov; 90(5):739-43. PubMed ID: 9351756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inference for a linear regression model with an interval-censored covariate.
    Gómez G; Espinal A; W Lagakos S
    Stat Med; 2003 Feb; 22(3):409-25. PubMed ID: 12529872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal HIV-1 DNA load and mother-to-child transmission.
    Arvold ND; Ngo-Giang-Huong N; McIntosh K; Suraseranivong V; Warachit B; Piyaworawong S; Changchit T; Lallemant M; Jourdain G;
    AIDS Patient Care STDS; 2007 Sep; 21(9):638-43. PubMed ID: 17919090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maximum likelihood inference for left-censored HIV RNA data.
    Lynn HS
    Stat Med; 2001 Jan; 20(1):33-45. PubMed ID: 11135346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling HIV-RNA viral load in vertically infected children.
    Gray L; Cortina-Borja M; Newell ML
    Stat Med; 2004 Mar; 23(5):769-81. PubMed ID: 14981674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in plasma HIV-1-RNA viral load and CD4 cell counts, and lack of zidovudine resistance among pregnant women receiving short-course zidovudine.
    Ekpini RA; Nkengasong JN; Sibailly T; Maurice C; Adjé C; Monga BB; Roels TH; Greenberg AE; Wiktor SZ
    AIDS; 2002 Mar; 16(4):625-30. PubMed ID: 11873007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of cell-free human immunodeficiency virus in cervicovaginal secretions is independent of viral load in the blood of human immunodeficiency virus-infected women.
    Rasheed S; Li Z; Xu D; Kovacs A
    Am J Obstet Gynecol; 1996 Jul; 175(1):122-9. PubMed ID: 8694037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do HIV type 1 RNA levels provide additional prognostic value to CD4(+) T lymphocyte counts in patients with advanced HIV type 1 infection?
    Arduino JM; Fischl MA; Stanley K; Collier AC; Spiegelman D
    AIDS Res Hum Retroviruses; 2001 Aug; 17(12):1099-105. PubMed ID: 11522179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
    Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral load, viral phenotype modification, zidovudine susceptibility and reverse transcriptase mutations during the first 6 months of zidovudine monotherapy in HIV-1-infected people.
    Rusconi S; De Pasquale MP; Mainini F; Bulgheroni E; Kurtagic S; Gori A; Violin M; Zanchetta N; Moroni M; Balotta C; Galli M
    Antivir Ther; 1996 Dec; 1(4):211-9. PubMed ID: 11324823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
    Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
    HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correspondence between the effect of zidovudine plus lamivudine on plasma HIV level/CD4 lymphocyte count and the incidence of clinical disease in infected individuals. North American Lamivudine HIV Working Group.
    Phillips AN; Eron J; Bartlett J; Kuritzkes DR; Johnson VA; Gilbert C; Johnson J; Keller A; Hill AM
    AIDS; 1997 Feb; 11(2):169-75. PubMed ID: 9030363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial. Italy, The Netherlands, Canada and Australia Study.
    Montaner JS; Reiss P; Cooper D; Vella S; Harris M; Conway B; Wainberg MA; Smith D; Robinson P; Hall D; Myers M; Lange JM
    JAMA; 1998 Mar; 279(12):930-7. PubMed ID: 9544767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal herpes simplex virus type 2 coinfection increases the risk of perinatal HIV transmission: possibility to further decrease transmission?
    Bollen LJ; Whitehead SJ; Mock PA; Leelawiwat W; Asavapiriyanont S; Chalermchockchareonkit A; Vanprapar N; Chotpitayasunondh T; McNicholl JM; Tappero JW; Shaffer N; Chuachoowong R
    AIDS; 2008 Jun; 22(10):1169-76. PubMed ID: 18525263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.